Publications
- Perez, D.C., Hernandez-Franco, J.F. & HogenEsch, H. Aluminum adjuvants differentially induce IL-1β release in vitro yet share NLRP3 inflammasome-independent adjuvant effects in vivo. Sci Rep (2026),16:4570.
- Hernandez-Franco JF, AbdelKhalek A, Zhang L, Ibrahium OM, Castillo Perez D, Flora D, Upatising V, Ostafe R, HogenEsch H (2026) Role of adjuvants in the efficacy of an IZUMO1-based immunocontraceptive vaccine in mice. Vaccine, 72: 128071.
- Hernandez-Franco JF, Gude S, Morrison RA, Castillo Perez D, Voytik-Harbin SL, HogenEsch H (2025) In-situ self-assembling oligomeric collagen scaffold enhances vaccine retention and vaccine-induced humoral immunity. Vaccines 13:1146.
- Hernandez-Franco JF, Jan IM, Elzey BD, HogenEsch H (2024) Intradermal vaccination with a phytoglycogen-based nanoparticle adjuvant combined with a STING agonist induces cytotoxic T lymphocyte-mediated antitumor immunity. NPJ Vaccines 9:149.
- Hernandez-Franco JF, Yadagiri G, Patil V, Bugybayeva D, Dolatyabi S, Dumkliang E, Singh MK, Suresh R, Akter F, Schrock J, Renukaradhya GJ, HogenEsch H (2023) Intradermal vaccination against influenza with a STING-targeted nanoparticle combination adjuvant induces superior cross-protective humoral immunity in swine compared with intranasal and intramuscular immunization. Vaccines, 11: 1699.
- HogenEsch H, Orr MT, Fox CB (2023) Vaccine adjuvants: Mechanisms of action. In: Vaccine Development: From Concept to Clinic. Prasad KA, Ed. Royal Soc Chem, Cambridge, UK
- Hernandez-Franco J, Mosley YC, Franco J, Ragland D, Yao Y, HogenEsch H (2021) Effective and safe stimulation of humoral and cell-mediated immunity by intradermal immunization with a cyclic dinucleotide/nanoparticle combination adjuvant. J Immunol, 206: 700-711.
- HogenEsch H, O'Hagan DT, Fox CB (2018) Optimizing the utilization of aluminum adjuvants in vaccines: you might just get what you want. NPJ Vaccines, 3:51.
